image
Healthcare - Biotechnology - NASDAQ - US
$ 13.575
-5.17 %
$ 1.62 B
Market Cap
-13.23
P/E
Price Target Average
26.28%
Revenue Forecast Estimate
42.23%
EBIT Estimate
8.03%
Net Income Estimate
44.38%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Arcutis Biotherapeutics, Inc.
image
Wall Street analysts predict an average 1-year price target for ARQT of $17.1 , with forecasts ranging from a low of $8 to a high of $19 .
ARQT Lowest Price Target Wall Street Target
8 USD -41.07%
ARQT Average Price Target Wall Street Target
17.1 USD 26.28%
ARQT Highest Price Target Wall Street Target
19 USD 39.96%
Price
Max Price Target
Min Price Target
Average Price Target
2020181816161414121210108866Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
REVENUE FORECAST

Revenue Forecast Chart ARQT

image
$900.0m$900.0m$800.0m$800.0m$700.0m$700.0m$600.0m$600.0m$500.0m$500.0m$400.0m$400.0m$300.0m$300.0m$200.0m$200.0m$100.0m$100.0m$0.0$0.02022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart ARQT

image
$50.0m$50.0m$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)($250.0m)($250.0m)($300.0m)($300.0m)2022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart ARQT

image
$400.0m$400.0m$300.0m$300.0m$200.0m$200.0m$100.0m$100.0m$0.0$0.0($100.0m)($100.0m)($200.0m)($200.0m)($300.0m)($300.0m)($400.0m)($400.0m)($500.0m)($500.0m)2022202220232023202420242025202520262026202720272028202820292029